From prodrug to pro-prodrug: hypoxia-sensitive antibody-drug conjugates

Signal Transduct Target Ther. 2022 Jan 21;7(1):20. doi: 10.1038/s41392-021-00833-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Hypoxia / drug effects
  • Cell Line, Tumor
  • Humans
  • Immunoconjugates* / chemistry
  • Immunoconjugates* / pharmacokinetics
  • Immunoconjugates* / pharmacology
  • Prodrugs* / chemistry
  • Prodrugs* / pharmacokinetics
  • Prodrugs* / pharmacology

Substances

  • Immunoconjugates
  • Prodrugs